Zarxio

Active Ingredient(s): Filgrastim-sndz
FDA Approved: * March 6, 2015
Pharm Company: * SANDOZ INC
Category: Cancer

Filgrastim, sold under the brand name Neupogen among others, is a medication used to treat low neutrophil count.[6] Low neutrophil counts may occur with HIV/AIDS, following chemotherapy or radiation poisoning, or be of an unknown cause.[6] It may also be used to increase white blood cells for gathering during leukapheresis.[6] It is given either by injection into a vein or under the skin.[6] Common side effects include fever, cou... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Zarxio 300 ug/.5ml Intravenous; Subcutaneous Injection, Solution
NDC: 61314-304
Labeler:
Sandoz Inc
Zarxio 480 ug/.8ml Intravenous; Subcutaneous Injection, Solution
NDC: 61314-312
Labeler:
Sandoz Inc
Zarxio 300 ug/.5ml Intravenous; Subcutaneous Injection, Solution
NDC: 61314-318
Labeler:
Sandoz Inc.
Zarxio 480 ug/.8ml Intravenous; Subcutaneous Injection, Solution
NDC: 61314-326
Labeler:
Sandoz Inc.

Related Brands

Drugs with the same active ingredients